Gazette Tracker
Gazette Tracker

Core Purpose

Revises ceiling prices of coronary stents effective April 1, 2025, based on a 1.74028% wholesale price index adjustment for 2024.

Detailed Summary

The National Pharmaceutical Pricing Authority, under the Ministry of Chemicals and Fertilizers, issues an order revising the ceiling prices for coronary stents. This revision, effective from April 1, 2025, is based on a 1.74028% Wholesale Price Index (WPI) adjustment for 2024 compared to 2023. The order specifies revised ceiling prices for Bare Metal Stents (₹10692.69) and Drug Eluting Stents (₹38933.14). Existing manufacturers and importers can adjust their MRP accordingly, and Goods and Services Tax can be added if applicable. Retailers are obligated to display price lists as per the Drugs (Prices Control) Order, 2013. Non-compliance may lead to penalties under the DPCO, 2013 and the Essential Commodities Act, 1955.

Full Text

REGD. No. D. L.-33004/99 The Gazette of India CG-DL-E-27032025-262012 EXTRAORDINARY PART II-Section 3-Sub-section (ii) PUBLISHED BY AUTHORITY No. 1455] NEW DELHI, THURSDAY, MARCH 27, 2025/CHAITRA 6, 1947 MINISTRY OF CHEMICALS AND FERTILIZERS (Department of Pharmaceuticals) (NATIONAL PHARMACEUTICAL PRICING AUTHORITY) ORDER New Delhi, the 27th March, 2025 S.O. 1473(E). In continuation of the notifications issued by National Pharmaceutical Pricing Authority, Department of Pharmaceuticals, Ministry of Chemical and Fertilizers vide S.O. 639(E) dated 12.02.2018, S.O. 1464(E) dated 02.04.2018, S.O. 1488(E) dated 29.03.2019, SO. 1217(E) dated 25.03.2020, S.O. 1334(E) dated 25.03.2021, 1502(E) dated 30.03.2022, 5249(E) dated 11.11.2022, 1572(E) dated 31.03.2023, 4663(E) dated 25.10.2023, 1551(E) dated 26.03.2024 and 1605 (E) dated 03.04.2024 regarding the fixation of ceiling price of the Coronary Stents as specified in column no. (2) mentioned in the table below; after considering the Wholesale Price Index (WPI) @ 1.74028% for the year 2024 over 2023, it has been decided to revise the ceiling prices of Coronary Stents as mentioned in column no. (4) in the table below, exclusive of Goods and Services Tax as applicable, and unit specified in column (3) with effect from 01.04.2025, as under: TABLE +-----+-----------------------------------------------------+-----------+---------------------+ | S1. | Coronary Stents | Unit | Ceiling price | | No | (Sl. No. 28 in Schedule-I of the DPCO, 2013) | (in | (w.e.f. 1.4.2025 | | | | Number) | with WPI @1.74028%) | | | | | (in Rs.) | +=====+=====================================================+===========+=====================+ | (1) | (2) | (3) | (4) | +-----+-----------------------------------------------------+-----------+---------------------+ | 1 | Bare Metal Stents | 1 | 10692.69 | +-----+-----------------------------------------------------+-----------+---------------------+ | 2 | Drug Eluting Stents (DES) including metallic DES | 1 | 38933.14 | | | and Bioresorbable Vascular Scaffold (BVS)/ | | | | | Biodegradable Stents | | | +-----+-----------------------------------------------------+-----------+---------------------+ Notes: - (a) All the existing manufacturers/importers of Coronary Stents having MRP lower than the ceiling price specified in column (4) in the above table (plus Goods and Services Taxes as applicable, if any), may revise the existing MRP of Coronary Stent, on the basis of WPI @ 1.74028% for the year 2024 over 2023 in accordance with Paragraph 16(2) of DPCO, 2013, read with Para 13(2) of DPCO, 2013. (b) The manufacturers/importers of Coronary Stents may add Goods and Services Taxes only if they have paid actually or if it is payable to the Government on the ceiling price mentioned in column (4) of the aforesaid table. (c) As per Para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer/importers, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same. (d) The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with Essential Commodities Act, 1955. [PN/263/131/2025/F/F. No. 8(131)/2025/D.P./NPPA-Div.-II ] RAJESH KUMAR T, Dy. Director Uploaded by Dte. of Printing at Government of India Press, Ring Road, Mayapuri, New Delhi-110064 and Published by the Controller of Publications, Delhi-110054.

Never miss important gazettes

Create a free account to save gazettes, add notes, and get email alerts for keywords you care about.

Sign Up Free